SEARCH

SEARCH BY CITATION

Keywords:

  • anti-smoking groups;
  • Big Pharma;
  • Nicotine Replacement Therapy;
  • smoking cessation;
  • tobacco control

Large pharmaceutical companies are major funders of anti-smoking lobby groups. The same firms manufacture the products used in Nicotine Replacement Therapy (NRT) and stand to gain when governments recommend this approach to smoking cessation. There is growing evidence, however, that NRT is less effective than ‘cold turkey’ methods, and, indeed, that it has a number of harmful side effects. Its continued promotion, together with counterproductive anti-smoking measures, raises serious questions about the influence of special interests over tobacco policy.